isirv Antiviral Group
Larisa Gubareva, Centers for Disease Control and Prevention, USA
Larisa Gubareva
Centers for Disease Control and Prevention, Atlanta, USA
Dr. Larisa Gubareva is the Lead of the Molecular Epidemiology Team in the Virus Surveillance and Diagnosis Branch, Influenza Division, at the Centers for Disease Control and Prevention in Atlanta, GA, USA. The Team actively participates in influenza virus surveillance and assessment of influenza virus susceptibility to FDA-approved and investigational antiviral agents. The Team also monitors influenza drug resistance among community isolates/specimens, offers antiviral testing for clinical care use in the US, and provides training and technical expertise to partners in global influenza virus surveillance.
Dr. Gubareva has been an influenza virologist for over 20 years. In 2006, she joined the Influenza Division at the CDC. Her research and public health activities focus on understanding the mechanisms of drug resistance, methods for drug resistance detection and assessment of drug resistant viruses’ replicative fitness. In recent years, she has served as a technical advisor for the WHO on the Influenza Antiviral Resistance.
Dr. Gubareva is an author/co-author of over 100 peer-reviewed papers and textbook chapters. She also serves on the editorial boards of the journals, Antimicrobial Agents and Chemotherapy, Antiviral Research, and Antiviral Chemistry & Chemotherapy. Dr. Gubareva is internationally recognized for her expertise in influenza antiviral research, as reflected by her various collaborative partners.
